reviewTop 10% cited

Levosimendan: Molecular mechanisms and clinical implications

International Journal of Cardiology · 2011 · Vol. 159(2) · pp. 82–87

Zoltán Papp✉(University of Debrecen)István Édes✉(University of Debrecen)Sonja Fruhwald✉(Medical University of Graz)Stefan De Hert✉(Ghent University Hospital)Markku Salmenperä✉(Helsinki University Hospital)Heli Leppikangas✉(Tampere University)Alexandre Mebazaa✉(Hôpital Lariboisière)Giovanni Landoni✉(Vita-Salute San Raffaele University)Elena Grossini✉(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)Philippe Primo Caimmi✉(Università degli Studi del Piemonte Orientale “Amedeo Avogadro”)Andrea Morelli✉(Sapienza University of Rome)Fabio Guarracino✉(Azienda Ospedaliera Universitaria Pisana)Robert H. G. Schwinger✉(Klinikum Weiden)Sven Meyer✉(Universität Hamburg)Lars Algotsson✉(Lund University)B. G. Wikström✉(Uppsala University Hospital)Kirsten Jörgensen✉(Sahlgrenska University Hospital)Gerasimos Filippatos✉(University General Hospital Attikon)John Parissis✉(University General Hospital Attikon)Martín J. García González✉(Hospital Universitario de Canarias)Alexander Parkhomenko✉(National Scientific Center "M.D. Strazhesko Institute of Cardiology")Mehmet Birhan Yılmaz✉(Sivas Cumhuriyet Üniversitesi)Matti Kivikko✉(Orion Corporation (Finland))Piero Pollesello✉(Orion Corporation (Finland))Ferenc Folláth✉(University Hospital of Zurich)